Numerous UT MD Anderson Meet the Experts are scheduled throughout ASCO. Note: All times are listed in Central Time.
Saturday, May 30
9:45–10:15 a.m.
Advances in lymphoma and multiple myeloma
Andrew Harkins, M.D.
Fellow, Cancer Medicine
Krina Patel, M.D.
Associate Professor, Lymphoma and Myeloma
10:30–11 a.m.
Preventive ethics in oncology
Nico Nortjé, Ph.D.
Associate Vice President, Clinical Ethics and Goal‑Concordant Care
Associate Professor, Critical Care Medicine
11–11:30 a.m.
Partnering with health systems to eliminate cancer
Andres Alvarez, M.D., Ph.D.
Baptist MD Anderson Cancer Center
Sumeet Bhatia, M.D.
Community Health Network MD Anderson Cancer Center
Jamin Morrison, M.D.
MD Anderson Cancer Center at Cooper
Naveen Pemmaraju, M.D.
Director, Leukemia for Cancer Network
Lei Zheng, M.D., Ph.D.
UT Health San Antonio MD Anderson Cancer Center
11:30 a.m.–12 p.m.
Clinical trials at UT MD Anderson
Christopher Flowers, M.D.
Division Head, Cancer Medicine
Jennifer Litton, M.D.
Chief Clinical Research Officer
Professor, Breast Medical Oncology
12:15–12:45 p.m.
Post-surgery management of brain metastases (Abstract LBA2000)
Hussein Tawbi, M.D., Ph.D.
Professor, Melanoma Medical Oncology
Jeffrey Weinberg, M.D.
Deputy Chair and Professor, Neurosurgery
1–1:30 p.m.
Spotlight on sarcoma, Part I
Anthony Conley, M.D.
Professor, Sarcoma Medical Oncology
Elise Nassif Haddad, M.D., Ph.D.
Assistant Professor, Sarcoma Medical Oncology
1:30–2 p.m.
Psychedelic-assisted therapies in oncology
Moran Amit, M.D., Ph.D.
Assistant Professor, Head and Neck Surgery
Assistant Professor, Genomic Medicine
3–3:30 p.m.
New horizons in kidney cancer treatment
Andrew Hahn, M.D.
Assistant Professor, Genitourinary Medical Oncology
Eric Jonasch, M.D.
Professor, Genitourinary Medical Oncology
Pavlos Msaouel, M.D., Ph.D.
Associate Professor, Genitourinary Medical Oncology
3–5 p.m.
UT MD Anderson President
Peter WT Pisters, M.D.
President
3:30–4 p.m.
KRAS: Not just one target, Part I
Shubham Pant, M.D., M.B.B.S.
Professor, Gastrointestinal Medical Oncology
4:15–4:45 p.m.
Practice-changing advances for non-small cell lung cancer
John Heymach, M.D., Ph.D.
Chair and Professor, Thoracic/Head and Neck Medical Oncology
Xiuning Le, M.D., Ph.D.
Associate Professor, Thoracic/Head and Neck Medical Oncology
Sunday, May 31
9–9:30 a.m.
The UT MD Anderson research enterprise
Albert Koong, M.D., Ph.D.
Chief Scientific Officer
Emily Roarty, Ph.D.
Vice President, Research Strategy and Impact
9:30–10 a.m.
Accelerating discoveries with industry partnerships
Emily Barnhill
Vice President, Strategic Industry Ventures
Aaron Spike
Director, Strategic Industry Ventures
9:30–10 a.m.
Advances in targeted therapy in leukemia
Musa Yilmaz, M.D.
Associate Professor, Leukemia
10:30–11 a.m.
The expansion of antibody drug conjugates
Carlos Torrado, M.D.
Assistant Professor, Investigational Cancer Therapeutics
Assistant Professor, Sarcoma Medical Oncology
11–11:30 a.m.
Integrative strategies for young-onset colorectal cancer, Part I
Josh Smith, M.D., Ph.D.
Chair and Professor, Colon and Rectal Surgery
Yi-Qian Nancy You, M.D.
Medical Director, Young-onset Colorectal Cancer Program
Professor, Colon & Rectal Surgery
11–11:30 a.m.
Advancing immunotherapy through novel combinations, Part I
Timothy Yap, M.B.B.S., Ph.D.
Vice President, Head of Clinical Development, Therapeutics Discovery Division
Professor, Department of Investigational Cancer Therapeutics
11:30 a.m.–12 p.m.
Training at UT MD Anderson: Hematology/oncology fellowship
Vince Cataldo, M.D.
Program Director, Hematology/Oncology Fellowship Program
Carl Gay, M.D., Ph.D.
Associate Program Director, Research
Associate Professor, Thoracic/Head and Neck Medical Oncology
Hannah Goulart, M.D.
Fellow, Cancer Medicine
Amishi Shah, M.D.
Associate Program Director, Hematology/Oncology Fellowship Program
12–12:30 p.m.
The gold standard in breast cancer treatment, Part II
Bora Lim, M.D.
Associate Professor, Breast Medical Oncology
David Ramirez, M.D.
Deputy Chair and Associate Professor, Breast Medical Oncology
12:30–1 p.m.
Integrative strategies for young-onset colorectal cancer, Part II
Van Morris, M.D.
Associate Professor, Gastrointestinal Medical Oncology
1:45–2:15 p.m.
The gold standard in breast cancer treatment, Part II
Sharon Giordano, M.D.
Chair and Professor, Breast Medical Oncology
4–4:30 p.m.
The interception of cancer
Eduardo Vilar-Sanchez, M.D., Ph.D.
Professor, Clinical Cancer Prevention
Professor, Gastrointestinal Medical Oncology
Monday, June 1
10–10:30 a.m.
Neoadjuvant therapy: Maximize cure and minimize harm
Lilie Lin, M.D.
Professor, Radiation Oncology
10:45–11:15 a.m.
Liquid biopsies as decision tools in colorectal cancer
Scott Kopetz, M.D., Ph.D.
Professor, Gastrointestinal Medical Oncology
11:15–11:45 a.m.
Advancing immunotherapy through novel combinations, Part II
Sarina Piha-Paul, M.D.
Professor, Investigational Cancer Therapeutics
11:30 a.m.–12 p.m.
Spotlight on sarcoma, Part II
Ahsan Farooqi, M.D., Ph.D.
Assistant Professor, Radiation Oncology
KRAS: Not just one target, Part II
11:30 a.m.–12 p.m.
David Hong, M.D.
Deputy Chair, Investigational Cancer Therapeutics
12–12:30 p.m.
Ferdinandos Skoulidis, M.D., Ph.D.
Associate Professor, Thoracic/Head and Neck Medical Oncology
2–2:30 p.m.
Multi-cancer early detection tests: Are we ready?
Mariana Chavez Mac Gregor, M.D.
Chair Ad Interim and Professor, Health Services Research
Professor, Breast Medical Oncology
Ernest Hawk, M.D.
Vice President, Cancer Prevention and Population Sciences